Cigna and Providence-Swedish Health Alliance ACO in Western Washington recently launched a care collaboration initiative that will benefit more than 7100 individuals who are covered by a Cigna health plan.
Cigna and Providence-Swedish Health Alliance ACO in Western Washington recently launched a care collaboration initiative that will benefit more than 7100 individuals who are covered by a Cigna health plan and who receive care from more than 1500 accountable care providers.
The Cigna Collaborative Care (CCC) program aims to act much like that of an accountable care organization by not only increasing patient access to healthcare and enhancing care coordination, but also by improving health outcomes, affordability, and patient experience.
When in effect, the care program will monitor and coordinate all aspects of a patient’s medical care, including overlooking missed health screenings or prescription refills, promoting preventive health visits, and improving follow-up care for people who may be transitioning from the hospital to home.
“I am excited to be adding Providence-Swedish Health Alliance to our CCC portfolio. Providence-Swedish Health Alliance shares our vision of changing the health care delivery system from one that rewards volume of care to one that puts the patient at the center and rewards quality of outcomes and value,” John Sobeck, MD, Cigna’s senior medical director, said in a statement.
The CCC program currently has 124 care arrangements in 29 states and comprises nearly 50,000 physicians.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Decitabine, Venetoclax Combo Boosts Survival in Patients With AML and MDS
May 16th 2024Study findings demonstrate that combining decitabine with venetoclax enhances molecular response rates in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), correlating strongly with improved clinical outcomes and overall survival.
Read More